ciprofibrate has been researched along with Insulin Sensitivity in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study was to determine whether treatment with the peroxisome proliferator-activated receptor-α (PPARα) agonist ciprofibrate has direct effects on cardiac and hepatic metabolism and can improve insulin sensitivity and cardiac function in insulin-resistant volunteers." | 5.69 | The tissue-specific metabolic effects of the PPARα agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover study. ( de Wit-Verheggen, VHW; Gemmink, A; Haas, J; Hesselink, MKC; Joris, PJ; Liénard, V; Montaigne, D; Nascimento, EBM; Phielix, E; Raiko, J; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; Staels, B; van de Weijer, T; Vanweert, F; Wierts, R; Wildberger, JE, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Wit-Verheggen, VHW | 1 |
| Vanweert, F | 1 |
| Raiko, J | 1 |
| Liénard, V | 1 |
| Schaart, G | 1 |
| Gemmink, A | 1 |
| Nascimento, EBM | 1 |
| Hesselink, MKC | 1 |
| Wildberger, JE | 1 |
| Wierts, R | 1 |
| Joris, PJ | 1 |
| Haas, J | 1 |
| Montaigne, D | 1 |
| Staels, B | 1 |
| Phielix, E | 1 |
| Schrauwen, P | 1 |
| Schrauwen-Hinderling, VB | 1 |
| van de Weijer, T | 1 |
1 trial available for ciprofibrate and Insulin Sensitivity
| Article | Year |
|---|---|
The tissue-specific metabolic effects of the PPARα agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover study.
Topics: Cross-Over Studies; Fluorodeoxyglucose F18; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance | 2023 |